BlueWhale Bio
$5.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
BlueWhale Bio is currently valued at $52.0M as of October 16, 2025. The company has raised a total of $23.0M in funding.
Capital Efficiency
With a capital efficiency ratio of 2.26x, BlueWhale Bio has achieved a valuation that is 2.26 times the total capital raised. This metric indicates moderate capital efficiency.
Investment Perspective
BlueWhale Bio's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is BlueWhale Bio Worth in 2025?
As of 2025, BlueWhale Bio is valued at $52.0M, based on the company's Early Stage VC funding round in October 16, 2025. This valuation positions BlueWhale Bio as one of the leading private companies in the sector.
BlueWhale Bio Valuation History
BlueWhale Bio's funding history demonstrates steady growth and investor confidence.
How BlueWhale Bio Valuation is Determined
Private company valuations like BlueWhale Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
BlueWhale Bio Valuation FAQs
Is BlueWhale Bio profitable?
BlueWhale Bio has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does BlueWhale Bio's valuation compare to competitors?
BlueWhale Bio is valued at $52.0M, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will BlueWhale Bio IPO?
BlueWhale Bio has not announced plans for an initial public offering. Until an IPO, investors can access BlueWhale Bio shares through secondary market platforms.